Indian Billionaire Dilip Shanghvi’s Sun Pharma To Buy U.S. Cancer Drug Maker For $355 Million
Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy and ...
Hindustan Times15d
Sun Pharma to buy US-based oncology firm with new skin cancer treatment product for $355 million
Sun Pharmaceutical Industries Ltd is buying US-based immunotherapy and oncology firm Checkpoint Therapeutics Inc. for $355 million. A bird flies past the logo of Sun Pharma installed on the facade ...